It might be less profitable if you view cancer treatment as MRR. Actuarial tables tell you that this MRR will certainly end unless you produce remission and so

It might be less profitable if you view cancer treatment as MRR. Actuarial tables tell you that this MRR will certainly end unless you produce remission and so I'm not sure if that is a good reason for them to not release it as a single dose. Though, there's no reason they wouldn't divide the dose. Charge say 375,000 instead 200,000 for the treatment using 3 doses instead of 1. But then the question is asked - why wouldn't they just release the treatment at 375,000 then?